chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Pyrexia, Respiratory symptom, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 03/30/21 COVID vaccine dose #1 (J&J) 08/02/21 Pt presents to ED reporting exposure to patient with respiratory symptoms ~12 days ago (07/21); states he has symptoms of malaise, body aches, subjective fevers, cough, SOB, and 1-2 loose stools/day for the past 9 days (07/25); CXR bilateral pneumonia, inflammatory markers slightly elevated; admitted for COVID pneumonia; COVID POSITIVE 08/03/21 Treated inpatient with dexamethasone, remdesivir, albuterol/ipratropium 08/05/21 Pt requires oxygen on and off, mainly at night time 08/06/21 Pt discharged home with rx for famotidine, dexamethasone, and albuterol/ipratropium
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient was on hospice
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash vesicular
Clinical narrative: Narrative: The exact date of reaction is unknow. On the patient's second moderna vaccine he experienced a rash which the patient described as blisters scattering to different parts of his body including thumb, shoulder, bilateral buttocks. This reaction was resolved with Medrol dosepak.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Narrative:  Product storage and handling error lead to expired produce being administered to 31 patients. Expired vaccine that was administered 8/19/2021 was transferred from -70 freezer to -20 freezer on June, 30, 2021 according to Pharmacy Supervisor. With the manufacturer 14 day expiration in the -20 freezer, vaccine would have expired on 7/13/2021. Vaccine was removed from -20 freezer and placed in refrigerator to be prepared for administration. The administration happened after 14 day shelf-life from -20 freezer had expired. Storage requirements from -70C to -20C freezer are different, including different shelf-life based on labelled expiration dates. Affected individuals information is being pulled. This information will be reported when available. There were 31 patients affected in this product handling and administration error. LLT Code 10063973 EXPIRED VACCINE USED PT Code 10074902 EXPIRED PRODUCT ADMINISTEREDL LLT Code 10079843 PRODUCT STORAGE ERROR PT Code 10079843 PRODUCT STORAGE ERROR
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 02/25/21 COVID vaccine dose #1 03/27/21 COVID vaccine dose #2 08/02/21 Pt presents to screening reporting exposure to COVID positive daughter and symptoms of cough, fever, and runny nose since 07/30; COVID POSITIVE 08/03/21 Pt reports all symptoms have resolved - chills, cough, diarrhea, loss of taste/smell, muscle pain, runny nose, sore throat; states runny nose started 07/29
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Exposure to SARS-CoV-2, Myalgia, Oropharyngeal pain, Pyrexia
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 02/25/21 COVID vaccine dose #1 03/27/21 COVID vaccine dose #2 08/02/21 Pt presents to screening reporting exposure to COVID positive daughter and symptoms of cough, fever, and runny nose since 07/30; COVID POSITIVE 08/03/21 Pt reports all symptoms have resolved - chills, cough, diarrhea, loss of taste/smell, muscle pain, runny nose, sore throat; states runny nose started 07/29
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 02/25/21 COVID vaccine dose #1 03/27/21 COVID vaccine dose #2 08/02/21 Pt presents to screening reporting exposure to COVID positive daughter and symptoms of cough, fever, and runny nose since 07/30; COVID POSITIVE 08/03/21 Pt reports all symptoms have resolved - chills, cough, diarrhea, loss of taste/smell, muscle pain, runny nose, sore throat; states runny nose started 07/29
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, Anticoagulant therapy, Aortic valve replacement, Atrial fibrillation
Clinical narrative: Narrative: 8/27/21: S: patient is doing much better this morning. Heart rate is much better and patient is down to FiO2 of 45%. Patient continues to ask when he can get out of the hospital. O: General- Patient sitting in the chair by the bedside and looks significantly better today, patient remains on high flow at 45% but satting around 95% Heart-irregular rate and rhythm with heart rate in the mid 80s this morning Lungs-crackles noted in the bases Abd- soft Ext- No LE edema Neuro- CN 2- 12 grossly intact A/P: patient is a 70-year-old male who admitted on 8/16/2021 with acute hypoxic respiratory failure due to Covid. Patient remains on high flow but we are working on weaning off 1. Acute COVID 19 pneumonia -S/O mRNA COVID-19 vaccine x 2 -S/P Tocilizumab on 8/17/21 - Patient has now completed remdesivir but remains on steroids and patient should complete steroids on 8/29/2021 2. Acute hypoxic respiratory failure - This is due to the Covid pneumonia and continue weaning oxygen to keep oxygen saturation to 88% and greater -Patient has been weaned further and FiO2 currently 45% 3. Elevated D Dimer -CTA was done on 8/23/21 that was negative for PE so currently on prophylactic Lovenox 4. CAD -S/P 4-vessel CABG -stable, no chest pain -continue medical management 5. Acute on chronic combined systolic & diastolic CHF (HFrEF) -LVEF ~ 25-30% -compensated, no peripheral edema - continue Torsemide -Entresto on hold due to hypotension 6. Chronic peristant atrial fibrillation -S/P AVR -Patient required some IV metoprolol on 8/24/2021 for elevated heart rate -Patient's metoprolol has been increased however unable to go up any further given some hypotension -Cardiology consulted and we have placed the patient on digoxin and heart rate seems significantly better today - Continue digoxin 0.25 mg p.o. daily - CHADVASC score noted to be 2 but has been documented extensively in the past that the patient is not a candidate for anticoagulation given recurrent GI bleeds 7. Hypotension -Now seems resolved 8. Stage IIIb CKD -Creatinine this morning was noted to be 1.2 and this is even better than the patient's baseline, patient's baseline creatinine appears to be 1.3-1.5 - Continue to follow intermittently 9. Diabetes mellitus, type 2 -Blood sugars currently acceptable and patient is currently on a regimen of 20 units of glargine along with sliding scale insulin -Continue this regimen 10. Generalized anxiety with slight panic attacks -secondary to acute medical illness - Seems resolved at present -Physical therapy and Occupational Therapy following and recommendation is for home health at the time of discharge 11. Obesity with a BMI of 64 -Patient counseled about weight loss 12. Hypocalcemia -Very mild at 7.2 but when corrected for albumin is almost within normal limits -We will give 1 g today F/E/N-cardiac diet Prophylaxis-prophylactic Lovenox Full code Dispo: Home with home health once medically stable. Continue weaning oxygen. Patient will transfer to the floor today.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Blood albumin abnormal, Blood calcium decreased, Blood creatinine increased, Blood glucose normal, COVID-19
Clinical narrative: Narrative: 8/27/21: S: patient is doing much better this morning. Heart rate is much better and patient is down to FiO2 of 45%. Patient continues to ask when he can get out of the hospital. O: General- Patient sitting in the chair by the bedside and looks significantly better today, patient remains on high flow at 45% but satting around 95% Heart-irregular rate and rhythm with heart rate in the mid 80s this morning Lungs-crackles noted in the bases Abd- soft Ext- No LE edema Neuro- CN 2- 12 grossly intact A/P: patient is a 70-year-old male who admitted on 8/16/2021 with acute hypoxic respiratory failure due to Covid. Patient remains on high flow but we are working on weaning off 1. Acute COVID 19 pneumonia -S/O mRNA COVID-19 vaccine x 2 -S/P Tocilizumab on 8/17/21 - Patient has now completed remdesivir but remains on steroids and patient should complete steroids on 8/29/2021 2. Acute hypoxic respiratory failure - This is due to the Covid pneumonia and continue weaning oxygen to keep oxygen saturation to 88% and greater -Patient has been weaned further and FiO2 currently 45% 3. Elevated D Dimer -CTA was done on 8/23/21 that was negative for PE so currently on prophylactic Lovenox 4. CAD -S/P 4-vessel CABG -stable, no chest pain -continue medical management 5. Acute on chronic combined systolic & diastolic CHF (HFrEF) -LVEF ~ 25-30% -compensated, no peripheral edema - continue Torsemide -Entresto on hold due to hypotension 6. Chronic peristant atrial fibrillation -S/P AVR -Patient required some IV metoprolol on 8/24/2021 for elevated heart rate -Patient's metoprolol has been increased however unable to go up any further given some hypotension -Cardiology consulted and we have placed the patient on digoxin and heart rate seems significantly better today - Continue digoxin 0.25 mg p.o. daily - CHADVASC score noted to be 2 but has been documented extensively in the past that the patient is not a candidate for anticoagulation given recurrent GI bleeds 7. Hypotension -Now seems resolved 8. Stage IIIb CKD -Creatinine this morning was noted to be 1.2 and this is even better than the patient's baseline, patient's baseline creatinine appears to be 1.3-1.5 - Continue to follow intermittently 9. Diabetes mellitus, type 2 -Blood sugars currently acceptable and patient is currently on a regimen of 20 units of glargine along with sliding scale insulin -Continue this regimen 10. Generalized anxiety with slight panic attacks -secondary to acute medical illness - Seems resolved at present -Physical therapy and Occupational Therapy following and recommendation is for home health at the time of discharge 11. Obesity with a BMI of 64 -Patient counseled about weight loss 12. Hypocalcemia -Very mild at 7.2 but when corrected for albumin is almost within normal limits -We will give 1 g today F/E/N-cardiac diet Prophylaxis-prophylactic Lovenox Full code Dispo: Home with home health once medically stable. Continue weaning oxygen. Patient will transfer to the floor today.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cardiac assistance device user, Cardiac failure, Cardiac failure acute, Cardiac failure congestive
Clinical narrative: Narrative: 8/27/21: S: patient is doing much better this morning. Heart rate is much better and patient is down to FiO2 of 45%. Patient continues to ask when he can get out of the hospital. O: General- Patient sitting in the chair by the bedside and looks significantly better today, patient remains on high flow at 45% but satting around 95% Heart-irregular rate and rhythm with heart rate in the mid 80s this morning Lungs-crackles noted in the bases Abd- soft Ext- No LE edema Neuro- CN 2- 12 grossly intact A/P: patient is a 70-year-old male who admitted on 8/16/2021 with acute hypoxic respiratory failure due to Covid. Patient remains on high flow but we are working on weaning off 1. Acute COVID 19 pneumonia -S/O mRNA COVID-19 vaccine x 2 -S/P Tocilizumab on 8/17/21 - Patient has now completed remdesivir but remains on steroids and patient should complete steroids on 8/29/2021 2. Acute hypoxic respiratory failure - This is due to the Covid pneumonia and continue weaning oxygen to keep oxygen saturation to 88% and greater -Patient has been weaned further and FiO2 currently 45% 3. Elevated D Dimer -CTA was done on 8/23/21 that was negative for PE so currently on prophylactic Lovenox 4. CAD -S/P 4-vessel CABG -stable, no chest pain -continue medical management 5. Acute on chronic combined systolic & diastolic CHF (HFrEF) -LVEF ~ 25-30% -compensated, no peripheral edema - continue Torsemide -Entresto on hold due to hypotension 6. Chronic peristant atrial fibrillation -S/P AVR -Patient required some IV metoprolol on 8/24/2021 for elevated heart rate -Patient's metoprolol has been increased however unable to go up any further given some hypotension -Cardiology consulted and we have placed the patient on digoxin and heart rate seems significantly better today - Continue digoxin 0.25 mg p.o. daily - CHADVASC score noted to be 2 but has been documented extensively in the past that the patient is not a candidate for anticoagulation given recurrent GI bleeds 7. Hypotension -Now seems resolved 8. Stage IIIb CKD -Creatinine this morning was noted to be 1.2 and this is even better than the patient's baseline, patient's baseline creatinine appears to be 1.3-1.5 - Continue to follow intermittently 9. Diabetes mellitus, type 2 -Blood sugars currently acceptable and patient is currently on a regimen of 20 units of glargine along with sliding scale insulin -Continue this regimen 10. Generalized anxiety with slight panic attacks -secondary to acute medical illness - Seems resolved at present -Physical therapy and Occupational Therapy following and recommendation is for home health at the time of discharge 11. Obesity with a BMI of 64 -Patient counseled about weight loss 12. Hypocalcemia -Very mild at 7.2 but when corrected for albumin is almost within normal limits -We will give 1 g today F/E/N-cardiac diet Prophylaxis-prophylactic Lovenox Full code Dispo: Home with home health once medically stable. Continue weaning oxygen. Patient will transfer to the floor today.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiomegaly, Chest X-ray abnormal, Chronic kidney disease, Coronary artery bypass, Coronary artery disease
Clinical narrative: Narrative: 8/27/21: S: patient is doing much better this morning. Heart rate is much better and patient is down to FiO2 of 45%. Patient continues to ask when he can get out of the hospital. O: General- Patient sitting in the chair by the bedside and looks significantly better today, patient remains on high flow at 45% but satting around 95% Heart-irregular rate and rhythm with heart rate in the mid 80s this morning Lungs-crackles noted in the bases Abd- soft Ext- No LE edema Neuro- CN 2- 12 grossly intact A/P: patient is a 70-year-old male who admitted on 8/16/2021 with acute hypoxic respiratory failure due to Covid. Patient remains on high flow but we are working on weaning off 1. Acute COVID 19 pneumonia -S/O mRNA COVID-19 vaccine x 2 -S/P Tocilizumab on 8/17/21 - Patient has now completed remdesivir but remains on steroids and patient should complete steroids on 8/29/2021 2. Acute hypoxic respiratory failure - This is due to the Covid pneumonia and continue weaning oxygen to keep oxygen saturation to 88% and greater -Patient has been weaned further and FiO2 currently 45% 3. Elevated D Dimer -CTA was done on 8/23/21 that was negative for PE so currently on prophylactic Lovenox 4. CAD -S/P 4-vessel CABG -stable, no chest pain -continue medical management 5. Acute on chronic combined systolic & diastolic CHF (HFrEF) -LVEF ~ 25-30% -compensated, no peripheral edema - continue Torsemide -Entresto on hold due to hypotension 6. Chronic peristant atrial fibrillation -S/P AVR -Patient required some IV metoprolol on 8/24/2021 for elevated heart rate -Patient's metoprolol has been increased however unable to go up any further given some hypotension -Cardiology consulted and we have placed the patient on digoxin and heart rate seems significantly better today - Continue digoxin 0.25 mg p.o. daily - CHADVASC score noted to be 2 but has been documented extensively in the past that the patient is not a candidate for anticoagulation given recurrent GI bleeds 7. Hypotension -Now seems resolved 8. Stage IIIb CKD -Creatinine this morning was noted to be 1.2 and this is even better than the patient's baseline, patient's baseline creatinine appears to be 1.3-1.5 - Continue to follow intermittently 9. Diabetes mellitus, type 2 -Blood sugars currently acceptable and patient is currently on a regimen of 20 units of glargine along with sliding scale insulin -Continue this regimen 10. Generalized anxiety with slight panic attacks -secondary to acute medical illness - Seems resolved at present -Physical therapy and Occupational Therapy following and recommendation is for home health at the time of discharge 11. Obesity with a BMI of 64 -Patient counseled about weight loss 12. Hypocalcemia -Very mild at 7.2 but when corrected for albumin is almost within normal limits -We will give 1 g today F/E/N-cardiac diet Prophylaxis-prophylactic Lovenox Full code Dispo: Home with home health once medically stable. Continue weaning oxygen. Patient will transfer to the floor today.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Crepitations, Ejection fraction decreased, Fibrin D dimer increased, Generalised anxiety disorder, Heart rate increased
Clinical narrative: Narrative: 8/27/21: S: patient is doing much better this morning. Heart rate is much better and patient is down to FiO2 of 45%. Patient continues to ask when he can get out of the hospital. O: General- Patient sitting in the chair by the bedside and looks significantly better today, patient remains on high flow at 45% but satting around 95% Heart-irregular rate and rhythm with heart rate in the mid 80s this morning Lungs-crackles noted in the bases Abd- soft Ext- No LE edema Neuro- CN 2- 12 grossly intact A/P: patient is a 70-year-old male who admitted on 8/16/2021 with acute hypoxic respiratory failure due to Covid. Patient remains on high flow but we are working on weaning off 1. Acute COVID 19 pneumonia -S/O mRNA COVID-19 vaccine x 2 -S/P Tocilizumab on 8/17/21 - Patient has now completed remdesivir but remains on steroids and patient should complete steroids on 8/29/2021 2. Acute hypoxic respiratory failure - This is due to the Covid pneumonia and continue weaning oxygen to keep oxygen saturation to 88% and greater -Patient has been weaned further and FiO2 currently 45% 3. Elevated D Dimer -CTA was done on 8/23/21 that was negative for PE so currently on prophylactic Lovenox 4. CAD -S/P 4-vessel CABG -stable, no chest pain -continue medical management 5. Acute on chronic combined systolic & diastolic CHF (HFrEF) -LVEF ~ 25-30% -compensated, no peripheral edema - continue Torsemide -Entresto on hold due to hypotension 6. Chronic peristant atrial fibrillation -S/P AVR -Patient required some IV metoprolol on 8/24/2021 for elevated heart rate -Patient's metoprolol has been increased however unable to go up any further given some hypotension -Cardiology consulted and we have placed the patient on digoxin and heart rate seems significantly better today - Continue digoxin 0.25 mg p.o. daily - CHADVASC score noted to be 2 but has been documented extensively in the past that the patient is not a candidate for anticoagulation given recurrent GI bleeds 7. Hypotension -Now seems resolved 8. Stage IIIb CKD -Creatinine this morning was noted to be 1.2 and this is even better than the patient's baseline, patient's baseline creatinine appears to be 1.3-1.5 - Continue to follow intermittently 9. Diabetes mellitus, type 2 -Blood sugars currently acceptable and patient is currently on a regimen of 20 units of glargine along with sliding scale insulin -Continue this regimen 10. Generalized anxiety with slight panic attacks -secondary to acute medical illness - Seems resolved at present -Physical therapy and Occupational Therapy following and recommendation is for home health at the time of discharge 11. Obesity with a BMI of 64 -Patient counseled about weight loss 12. Hypocalcemia -Very mild at 7.2 but when corrected for albumin is almost within normal limits -We will give 1 g today F/E/N-cardiac diet Prophylaxis-prophylactic Lovenox Full code Dispo: Home with home health once medically stable. Continue weaning oxygen. Patient will transfer to the floor today.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate irregular, Hypocalcaemia, Hypotension, Illness, Insulin therapy
Clinical narrative: Narrative: 8/27/21: S: patient is doing much better this morning. Heart rate is much better and patient is down to FiO2 of 45%. Patient continues to ask when he can get out of the hospital. O: General- Patient sitting in the chair by the bedside and looks significantly better today, patient remains on high flow at 45% but satting around 95% Heart-irregular rate and rhythm with heart rate in the mid 80s this morning Lungs-crackles noted in the bases Abd- soft Ext- No LE edema Neuro- CN 2- 12 grossly intact A/P: patient is a 70-year-old male who admitted on 8/16/2021 with acute hypoxic respiratory failure due to Covid. Patient remains on high flow but we are working on weaning off 1. Acute COVID 19 pneumonia -S/O mRNA COVID-19 vaccine x 2 -S/P Tocilizumab on 8/17/21 - Patient has now completed remdesivir but remains on steroids and patient should complete steroids on 8/29/2021 2. Acute hypoxic respiratory failure - This is due to the Covid pneumonia and continue weaning oxygen to keep oxygen saturation to 88% and greater -Patient has been weaned further and FiO2 currently 45% 3. Elevated D Dimer -CTA was done on 8/23/21 that was negative for PE so currently on prophylactic Lovenox 4. CAD -S/P 4-vessel CABG -stable, no chest pain -continue medical management 5. Acute on chronic combined systolic & diastolic CHF (HFrEF) -LVEF ~ 25-30% -compensated, no peripheral edema - continue Torsemide -Entresto on hold due to hypotension 6. Chronic peristant atrial fibrillation -S/P AVR -Patient required some IV metoprolol on 8/24/2021 for elevated heart rate -Patient's metoprolol has been increased however unable to go up any further given some hypotension -Cardiology consulted and we have placed the patient on digoxin and heart rate seems significantly better today - Continue digoxin 0.25 mg p.o. daily - CHADVASC score noted to be 2 but has been documented extensively in the past that the patient is not a candidate for anticoagulation given recurrent GI bleeds 7. Hypotension -Now seems resolved 8. Stage IIIb CKD -Creatinine this morning was noted to be 1.2 and this is even better than the patient's baseline, patient's baseline creatinine appears to be 1.3-1.5 - Continue to follow intermittently 9. Diabetes mellitus, type 2 -Blood sugars currently acceptable and patient is currently on a regimen of 20 units of glargine along with sliding scale insulin -Continue this regimen 10. Generalized anxiety with slight panic attacks -secondary to acute medical illness - Seems resolved at present -Physical therapy and Occupational Therapy following and recommendation is for home health at the time of discharge 11. Obesity with a BMI of 64 -Patient counseled about weight loss 12. Hypocalcemia -Very mild at 7.2 but when corrected for albumin is almost within normal limits -We will give 1 g today F/E/N-cardiac diet Prophylaxis-prophylactic Lovenox Full code Dispo: Home with home health once medically stable. Continue weaning oxygen. Patient will transfer to the floor today.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Left ventricular failure, Lung infiltration, Obesity, Panic attack, Type 2 diabetes mellitus
Clinical narrative: Narrative: 8/27/21: S: patient is doing much better this morning. Heart rate is much better and patient is down to FiO2 of 45%. Patient continues to ask when he can get out of the hospital. O: General- Patient sitting in the chair by the bedside and looks significantly better today, patient remains on high flow at 45% but satting around 95% Heart-irregular rate and rhythm with heart rate in the mid 80s this morning Lungs-crackles noted in the bases Abd- soft Ext- No LE edema Neuro- CN 2- 12 grossly intact A/P: patient is a 70-year-old male who admitted on 8/16/2021 with acute hypoxic respiratory failure due to Covid. Patient remains on high flow but we are working on weaning off 1. Acute COVID 19 pneumonia -S/O mRNA COVID-19 vaccine x 2 -S/P Tocilizumab on 8/17/21 - Patient has now completed remdesivir but remains on steroids and patient should complete steroids on 8/29/2021 2. Acute hypoxic respiratory failure - This is due to the Covid pneumonia and continue weaning oxygen to keep oxygen saturation to 88% and greater -Patient has been weaned further and FiO2 currently 45% 3. Elevated D Dimer -CTA was done on 8/23/21 that was negative for PE so currently on prophylactic Lovenox 4. CAD -S/P 4-vessel CABG -stable, no chest pain -continue medical management 5. Acute on chronic combined systolic & diastolic CHF (HFrEF) -LVEF ~ 25-30% -compensated, no peripheral edema - continue Torsemide -Entresto on hold due to hypotension 6. Chronic peristant atrial fibrillation -S/P AVR -Patient required some IV metoprolol on 8/24/2021 for elevated heart rate -Patient's metoprolol has been increased however unable to go up any further given some hypotension -Cardiology consulted and we have placed the patient on digoxin and heart rate seems significantly better today - Continue digoxin 0.25 mg p.o. daily - CHADVASC score noted to be 2 but has been documented extensively in the past that the patient is not a candidate for anticoagulation given recurrent GI bleeds 7. Hypotension -Now seems resolved 8. Stage IIIb CKD -Creatinine this morning was noted to be 1.2 and this is even better than the patient's baseline, patient's baseline creatinine appears to be 1.3-1.5 - Continue to follow intermittently 9. Diabetes mellitus, type 2 -Blood sugars currently acceptable and patient is currently on a regimen of 20 units of glargine along with sliding scale insulin -Continue this regimen 10. Generalized anxiety with slight panic attacks -secondary to acute medical illness - Seems resolved at present -Physical therapy and Occupational Therapy following and recommendation is for home health at the time of discharge 11. Obesity with a BMI of 64 -Patient counseled about weight loss 12. Hypocalcemia -Very mild at 7.2 but when corrected for albumin is almost within normal limits -We will give 1 g today F/E/N-cardiac diet Prophylaxis-prophylactic Lovenox Full code Dispo: Home with home health once medically stable. Continue weaning oxygen. Patient will transfer to the floor today.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to communicable disease, Headache, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/09 Pfizer, dose #1 03/01, Pfizer, dose #2 09/18 pt cc: cough, headache, myalgias, rhinorrhea exposure; unknown 09/21 COVID swab, result: detected 09/21 SARS-COV-S Variant Sequencing result: pending
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/09 Pfizer, dose #1 03/01, Pfizer, dose #2 09/18 pt cc: cough, headache, myalgias, rhinorrhea exposure; unknown 09/21 COVID swab, result: detected 09/21 SARS-COV-S Variant Sequencing result: pending
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Injection site pain, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, difficulty breathing, injection site pain Narrative: The morning after receiving a booster dose of the Moderna COVID-19 vaccine, the patient developed a headache, fever (temp unknown), injection site pain, and experienced some difficulty breathing. He took one dose of acetaminophen 500mg for his symptoms.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19-2
Symptoms: Lip swelling, Pruritus, Swelling face, Urticaria
Clinical narrative: Narrative: 61 y/o male reported to PCP for a scheduled follow up appt. States that he developed hives and itching after receiving his second dose of moderna. States he had no effects after the first shot in mid February. Tool the second shot in Mid march then end of May into June, developed facial swelling and lip swelling and also developed hives on various parts of his body (he took photos at the time and showed them to PCP). He went to an urgent care clinic and received a course of prednisone and hydroxyzine for itching. The symptoms resolved with this combination however the symptoms of itching and welts came back once medication course was completed. He had been using Benadryl over the counter which stopped the itching and firmly believes he is having an allergic reaction to the covid vaccine.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Headache, Myalgia, CHILLS Narrative:
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Hypoxia, Intensive care
Clinical narrative: Narrative:  82 yo male patient with comorbidities including CKD 3A, chronic pain, HTN, BPH, and unspecified HLD who presents with dyspnea and coughing. Really came to the hospital just for a swab but was noted to be hypoxic and was admitted. COVID positive test on 8/23/21 with symptom onset on 8/16/21. Patient was fully vaccinated with COVID vaccine (Pfizer in 2/11/21 and 3/4/21). Patient was initiated on Remdesivir and Dexamethasone but required transfer to ICU due to worsening hypoxia.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, SARS-CoV-2 test positive
Clinical narrative: Narrative:  82 yo male patient with comorbidities including CKD 3A, chronic pain, HTN, BPH, and unspecified HLD who presents with dyspnea and coughing. Really came to the hospital just for a swab but was noted to be hypoxic and was admitted. COVID positive test on 8/23/21 with symptom onset on 8/16/21. Patient was fully vaccinated with COVID vaccine (Pfizer in 2/11/21 and 3/4/21). Patient was initiated on Remdesivir and Dexamethasone but required transfer to ICU due to worsening hypoxia.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Angiogram pulmonary abnormal, Anosmia, COVID-19, Chest X-ray normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10, Pfizer, dose #2 09/22 COVID swab, result: detected 09/22 pt cc: cough, fatigue, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure; unknown 09/26 pt admit ED cc: cough, fatigue, dx: covid infection, hepatic fibrosis, lymph node enlargement LOS: 1 day 09/26 CTA PE impression: 1. Negative for pulmonary embolism. 2. Hepatic steatosis, and findings suggesting an underlying element of hepatic fibrosis. Suspected perigastric varices. 3. 8 mm pulmonary nodule within the right lower lobe. Follow-up examination in 6-12 months time is recommended to ensure stability. 09/26 CR impression: No pulmonary consolidation or overt edema identified. No pneumothorax or significant pleural effusion. Nonenlarged cardiac silhouette. 10/2 clinically resolved
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Gastric varices, Hepatic fibrosis, Hepatic steatosis
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10, Pfizer, dose #2 09/22 COVID swab, result: detected 09/22 pt cc: cough, fatigue, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure; unknown 09/26 pt admit ED cc: cough, fatigue, dx: covid infection, hepatic fibrosis, lymph node enlargement LOS: 1 day 09/26 CTA PE impression: 1. Negative for pulmonary embolism. 2. Hepatic steatosis, and findings suggesting an underlying element of hepatic fibrosis. Suspected perigastric varices. 3. 8 mm pulmonary nodule within the right lower lobe. Follow-up examination in 6-12 months time is recommended to ensure stability. 09/26 CR impression: No pulmonary consolidation or overt edema identified. No pneumothorax or significant pleural effusion. Nonenlarged cardiac silhouette. 10/2 clinically resolved
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Pulmonary mass, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10, Pfizer, dose #2 09/22 COVID swab, result: detected 09/22 pt cc: cough, fatigue, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure; unknown 09/26 pt admit ED cc: cough, fatigue, dx: covid infection, hepatic fibrosis, lymph node enlargement LOS: 1 day 09/26 CTA PE impression: 1. Negative for pulmonary embolism. 2. Hepatic steatosis, and findings suggesting an underlying element of hepatic fibrosis. Suspected perigastric varices. 3. 8 mm pulmonary nodule within the right lower lobe. Follow-up examination in 6-12 months time is recommended to ensure stability. 09/26 CR impression: No pulmonary consolidation or overt edema identified. No pneumothorax or significant pleural effusion. Nonenlarged cardiac silhouette. 10/2 clinically resolved
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Wheezing
Clinical narrative: CoughWheeze, FATIGUE Narrative:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received the 1st dose of COVID 19 vaccine on 6 August and test positive for covid 19 on 14 Aug 21 and was hospitalized with respiratory failure and COVID pneumonia. The patient was treated and discharged an oxygen on 8 September 2021. The EUA requires that any patients that test positive for COVID 19 and required hospitalization after receiving the vaccine must be reported.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Myalgia, Nausea, Vomiting
Clinical narrative: Headache, Myalgia, Diarrhea & Nausea Vomiting  Narrative:
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Joint stiffness, Myalgia
Clinical narrative: Headache, Myalgia, shoulder tightness, sweating, rigor, polyuria,  Narrative: N/A
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Polyuria
Clinical narrative: Headache, Myalgia, shoulder tightness, sweating, rigor, polyuria,  Narrative: N/A
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/29, Moderna , dose #1 02/26, Moderna , dose #2 09/24 pt cc: chills, cough, fatigue, exposure; daughter 10/01 COVID swab, result: detected 10/01 SARS-COV-2 Variant Sequencing result: pending
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/29, Moderna , dose #1 02/26, Moderna , dose #2 09/24 pt cc: chills, cough, fatigue, exposure; daughter 10/01 COVID swab, result: detected 10/01 SARS-COV-2 Variant Sequencing result: pending
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Headache, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/15, Pfizer, dose #1 02/12, Pfizer, dose #2 09/16 pt cc: cough, diarrhea, headache, rhinorrhea, exposure: unknown 09/27 COVID swab, result: detected 09/27 SARS-COV-2 Variant Sequencing result: pending 10/01 clinically resolved
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/15, Pfizer, dose #1 02/12, Pfizer, dose #2 09/16 pt cc: cough, diarrhea, headache, rhinorrhea, exposure: unknown 09/27 COVID swab, result: detected 09/27 SARS-COV-2 Variant Sequencing result: pending 10/01 clinically resolved
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Hypersensitivity, Rash, Rash pruritic, Urticaria
Clinical narrative: Narrative: Patient received her first dose of the Pfizer COVID-19 Vaccine on 8/16/21 at Facility. There was no obvious adverse/allergic reaction noted during the 15-minute monitoring period after she received the vaccine. However, later that afternoon, within 4 hours of receiving the vaccine she started noticing an itch rash with hives/welts on her side with some small bumps on her face as well. She did not experience any difficulty breathing or wheezing. This reaction qualified a non-severe but immediate allergic reaction to the first dose of vaccine because it occurred within 4 hours. Therefore, it is not recommended that she get a second dose of an mRNA vaccine.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Bronchial hyperreactivity, COVID-19, Chest X-ray normal
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 03/10/21 COVID vaccine dose #1 03/31/21 COVID vaccine dose #2 04/03/21 Pt resents to ED reporting cough, chest tightness, and difficulty breathing that started 04/02; CXR normal; discharged home with rx for medrol, albuterol/ipratropium, benzonatate for bronchial hyperreactivity; COVID NEGATIVE 05/13/21 Pt presents to clinic reporting symptoms of bronchial hyperreactivity has resolved 08/02/21 Pt presents to screening reporting cough, headache, and runny nose x1 day (08/01); COVID POSITIVE 08/03/21 Pt reports moderate cough, mild diarrhea, moderate fatigue, headache, runny nose, SOB, mild sore throat; rx given for benzonatate 08/06/21 Pt reports loss of taste/smell, sore throat. SOB with exertion, and improving cough, fatigue, and headache 08/07/21 Pt reports very mild cough and improving fatigue 08/12/21 Pt is clinically resolved
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Diarrhoea, Dyspnoea, Dyspnoea exertional
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 03/10/21 COVID vaccine dose #1 03/31/21 COVID vaccine dose #2 04/03/21 Pt resents to ED reporting cough, chest tightness, and difficulty breathing that started 04/02; CXR normal; discharged home with rx for medrol, albuterol/ipratropium, benzonatate for bronchial hyperreactivity; COVID NEGATIVE 05/13/21 Pt presents to clinic reporting symptoms of bronchial hyperreactivity has resolved 08/02/21 Pt presents to screening reporting cough, headache, and runny nose x1 day (08/01); COVID POSITIVE 08/03/21 Pt reports moderate cough, mild diarrhea, moderate fatigue, headache, runny nose, SOB, mild sore throat; rx given for benzonatate 08/06/21 Pt reports loss of taste/smell, sore throat. SOB with exertion, and improving cough, fatigue, and headache 08/07/21 Pt reports very mild cough and improving fatigue 08/12/21 Pt is clinically resolved
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 03/10/21 COVID vaccine dose #1 03/31/21 COVID vaccine dose #2 04/03/21 Pt resents to ED reporting cough, chest tightness, and difficulty breathing that started 04/02; CXR normal; discharged home with rx for medrol, albuterol/ipratropium, benzonatate for bronchial hyperreactivity; COVID NEGATIVE 05/13/21 Pt presents to clinic reporting symptoms of bronchial hyperreactivity has resolved 08/02/21 Pt presents to screening reporting cough, headache, and runny nose x1 day (08/01); COVID POSITIVE 08/03/21 Pt reports moderate cough, mild diarrhea, moderate fatigue, headache, runny nose, SOB, mild sore throat; rx given for benzonatate 08/06/21 Pt reports loss of taste/smell, sore throat. SOB with exertion, and improving cough, fatigue, and headache 08/07/21 Pt reports very mild cough and improving fatigue 08/12/21 Pt is clinically resolved
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Angiogram pulmonary normal, Anosmia, COVID-19, Chest X-ray normal
Clinical narrative: Narrative:  COVID infection following completion of COVID vaccine series 12/21/20 COVID vaccine dose #1 01/08/21 COVID vaccine dose #2 08/02/21 Pt presents to screening reporting cough, headache, runny nose x3 days (07/31); COVID POSITIVE 08/03/21 Pt reports mild chills, mild cough, low grade fever (99.5), headache that gets worse with coughing, loss of taste/smell, muscle pain, runny nose, and mild SOB 08/04/21 Pt reports constipation and intermittent hot flashes and chills 08/05/21 Pt reports symptoms resolving and fatigue is improving 08/13/21 Pt calls into clinic reporting pleuritic chest pain, severe cough, and wheezing; advised to go to ED; CXR and CTA from ED visit WNL; pt is discharged home with rx for prednisone, albuterol, and azithromycin 08/21/21 Pt reported to be doing better but with persistent cough; rx given for benzonatate and fluticasone/salmeterol
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Constipation, Cough, Dyspnoea, Fatigue
Clinical narrative: Narrative:  COVID infection following completion of COVID vaccine series 12/21/20 COVID vaccine dose #1 01/08/21 COVID vaccine dose #2 08/02/21 Pt presents to screening reporting cough, headache, runny nose x3 days (07/31); COVID POSITIVE 08/03/21 Pt reports mild chills, mild cough, low grade fever (99.5), headache that gets worse with coughing, loss of taste/smell, muscle pain, runny nose, and mild SOB 08/04/21 Pt reports constipation and intermittent hot flashes and chills 08/05/21 Pt reports symptoms resolving and fatigue is improving 08/13/21 Pt calls into clinic reporting pleuritic chest pain, severe cough, and wheezing; advised to go to ED; CXR and CTA from ED visit WNL; pt is discharged home with rx for prednisone, albuterol, and azithromycin 08/21/21 Pt reported to be doing better but with persistent cough; rx given for benzonatate and fluticasone/salmeterol
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Headache, Hot flush, Myalgia, Pleuritic pain
Clinical narrative: Narrative:  COVID infection following completion of COVID vaccine series 12/21/20 COVID vaccine dose #1 01/08/21 COVID vaccine dose #2 08/02/21 Pt presents to screening reporting cough, headache, runny nose x3 days (07/31); COVID POSITIVE 08/03/21 Pt reports mild chills, mild cough, low grade fever (99.5), headache that gets worse with coughing, loss of taste/smell, muscle pain, runny nose, and mild SOB 08/04/21 Pt reports constipation and intermittent hot flashes and chills 08/05/21 Pt reports symptoms resolving and fatigue is improving 08/13/21 Pt calls into clinic reporting pleuritic chest pain, severe cough, and wheezing; advised to go to ED; CXR and CTA from ED visit WNL; pt is discharged home with rx for prednisone, albuterol, and azithromycin 08/21/21 Pt reported to be doing better but with persistent cough; rx given for benzonatate and fluticasone/salmeterol
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Troponin normal, Wheezing
Clinical narrative: Narrative:  COVID infection following completion of COVID vaccine series 12/21/20 COVID vaccine dose #1 01/08/21 COVID vaccine dose #2 08/02/21 Pt presents to screening reporting cough, headache, runny nose x3 days (07/31); COVID POSITIVE 08/03/21 Pt reports mild chills, mild cough, low grade fever (99.5), headache that gets worse with coughing, loss of taste/smell, muscle pain, runny nose, and mild SOB 08/04/21 Pt reports constipation and intermittent hot flashes and chills 08/05/21 Pt reports symptoms resolving and fatigue is improving 08/13/21 Pt calls into clinic reporting pleuritic chest pain, severe cough, and wheezing; advised to go to ED; CXR and CTA from ED visit WNL; pt is discharged home with rx for prednisone, albuterol, and azithromycin 08/21/21 Pt reported to be doing better but with persistent cough; rx given for benzonatate and fluticasone/salmeterol
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count normal
Clinical narrative: Narrative:  COVID infection following completion of COVID vaccine series 12/21/20 COVID vaccine dose #1 01/08/21 COVID vaccine dose #2 08/02/21 Pt presents to screening reporting cough, headache, runny nose x3 days (07/31); COVID POSITIVE 08/03/21 Pt reports mild chills, mild cough, low grade fever (99.5), headache that gets worse with coughing, loss of taste/smell, muscle pain, runny nose, and mild SOB 08/04/21 Pt reports constipation and intermittent hot flashes and chills 08/05/21 Pt reports symptoms resolving and fatigue is improving 08/13/21 Pt calls into clinic reporting pleuritic chest pain, severe cough, and wheezing; advised to go to ED; CXR and CTA from ED visit WNL; pt is discharged home with rx for prednisone, albuterol, and azithromycin 08/21/21 Pt reported to be doing better but with persistent cough; rx given for benzonatate and fluticasone/salmeterol
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, General physical health deterioration, Malaise
Clinical narrative: Narrative:  Patient received two doses of Pfizer COVID 19 vaccine in Jan/Mar 2021. The patient tested positive for COVID 19 on 20 August 21 and was hospitalized for minor Covid symptoms. Over the next several weeks, the patient experienced significant worsening in COVID pneumonia symptoms and was treated. He was discharged and re-admitted on two occasions. The patient was then discharged to an LTAC and then the patient's condition worsened and the patient died on 22 September 2021.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received two doses of Pfizer COVID 19 vaccine in Jan/Mar 2021. The patient tested positive for COVID 19 on 20 August 21 and was hospitalized for minor Covid symptoms. Over the next several weeks, the patient experienced significant worsening in COVID pneumonia symptoms and was treated. He was discharged and re-admitted on two occasions. The patient was then discharged to an LTAC and then the patient's condition worsened and the patient died on 22 September 2021.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Myalgia
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 01/12/21 COVID vaccine dose #1 02/09/21 COVID vaccine dose #2 04/17/21 Pt presents for preop COVID test with no symptoms; COVID NEGATIVE 05/21/21 Pt presents for preop COVID test with no symptoms; COVID NEGATIVE 08/02/21 Pt presents to screening reporting cough and congestion; COVID POSITIVE 08/03/21 Pt states symptoms started 07/31; reports cough, fatigue, low grade fever, headache muscle pain; states urine incontinence started 08/02
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Urinary incontinence
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 01/12/21 COVID vaccine dose #1 02/09/21 COVID vaccine dose #2 04/17/21 Pt presents for preop COVID test with no symptoms; COVID NEGATIVE 05/21/21 Pt presents for preop COVID test with no symptoms; COVID NEGATIVE 08/02/21 Pt presents to screening reporting cough and congestion; COVID POSITIVE 08/03/21 Pt states symptoms started 07/31; reports cough, fatigue, low grade fever, headache muscle pain; states urine incontinence started 08/02
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Respiratory failure, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Narrative: Patient received COVID 19 vaccine in Feb/Mar 2021. The patient tested positive for COVID 19 on 17 August 2021 and was hospitalized for Covid Pneumonia. The patient was discharged on 18 August 2021, but was re-admitted on 23 August with COVID pneumonia, respiratory failure, and sepsis. The patient was treated and was discharged on 30 August 2021. The EUA requires reporting of patients that have received the vaccine and have been hospitalized with COVID 19.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cough, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient received two COVID 19 vaccine doses Feb/Mar 2021. The patient tested positive and was hospitalized for COVID 19 on 4 August 2021 with COVID pneumonia, fever, and cough. The patient was treated and symptoms improved. The patient was discharged on 6 August 2021. The EUA requires reporting of patients that have received the vaccine who have been hospitalized for COVID 19.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Hypoxia, Pyrexia
Clinical narrative: Narrative:  Patient received the two doses of COVID 19 Vaccine in Jan/Feb 2021. The patient tested positive on 15 August 2021 and was admitted to the hospital with fever, hypoxia, and COVID 19 pneumonia. The patient died due complications of covid 19 (sepsis, respiratory failure, and urinary tract infection, and COVID pneumonia). The EUA for the vaccine requires that all patients testing positive for COVID 19 and requiring hospitalization or death is reported.